Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
CANCER:
Thymoma
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
‹
Thymus Cancer (55
)
Thymic Carcinoma (34
)
Thymus Cancer (55
)
Thymic Carcinoma (34
)
›
Associations
(21)
News
Trials
Search handles
@HenningWillers
@MyriamChalabi
@chulkimMD
@g_mountzios
Search handles
@HenningWillers
@MyriamChalabi
@chulkimMD
@g_mountzios
Filter by
Latest
9ms
"Small cell, thymoma, and now mesothelioma... all on day 1. What a time to be alive!" - @kaushalpar discussing cfDNA detection of chromosomal junctions for mesothelioma at #DAVAHawaiiLung. Part of an excellent panel overall! (@KE_Gallaway)
9 months ago
10ms
@ArdeshirFatemeh giving us insights to predict disease progression in thymoma! Our fellows @IUHemOnc at @IUCancerCenter are amazing! #ASCO23 #ResearchCuresCancer (@JenSchwartzIUSM)
10 months ago
10ms
Hope you had the chance to see our amazing fellow @ArdeshirFatemeh and her poster on thymoma and predicting progression! @IUHemOnc @IUSMDeptMed @IUMedSchool (@JenSchwartzIUSM)
10 months ago
10ms
Quite incisive question there😉🙏 True, in practice it means more like no recurrence after 5 years (though longer for thymoma, breast ca, prostate ca), yet what does one do when there is a cytostatic drug in there for 3 years? 🧐 (@HenningWillers)
10 months ago
11ms
A very personal tweet; today I lost my kind, beautiful, loving cousin, my age, to a thymoma, a diagnosis made months after symptoms were labeled as depression in a war-torn country. Do not underestimate how lucky we are with the access to healthcare that we have. #unfair (@MyriamChalabi)
11 months ago
1year
3/4 8⃣ Stage III Thymoma @nicogirardcurie @DrSanjayPopat 9⃣ CM816,CONTACT-01,EMPower-Lung-03, RESILIENT update @nicogirardcurie @charlesrudin @JoelNealMD 🔟 Debate on duration of adj TKI @HelenaYu923 @Alfdoc2 1⃣1⃣ Debate on adj chemo in EGFR+ @LauraMezquitaMD @BenjaminBesseMD (@g_mountzios)
1 year ago
EGFR (Epidermal growth factor receptor)
over1year
Avelumab/axitinib in B3 thymoma & thymic carcinoma (CAVEATT) N=32 (thymic carcinoma majority) ORR=34% Similar PFS between between PD-L1 high vs. PD-L1 low/negative is notable Incidence of serious irAEs=12% (similar to PD-1 monoTx) @TheLancetOncol https://t.co/LQL8ueEWJQ (@chulkimMD)
over 1 year ago
PD-L1 (Programmed death ligand 1) • PD-1 (Programmed cell death 1)
|
PD-L1 underexpression • PD-L1 negative
|
Bavencio (avelumab) • Inlyta (axitinib)
2years
The purpose of this #meta-analysis is to characterize the association🔀 between PD-L1 expression and different stages of #thymoma 🆓🔗https://t.co/OJz3i5VnZh #thymiccarcinoma #rarecancer @Dr_Ivanoncologo @AbhijitSurgPath @smlungpathguy #pathology (@TumoriJ)
2 years ago
Retrospective data • IO biomarker
|
PD-L1 (Programmed death ligand 1)
|
PD-L1 expression
over2years
Targeting mTOR and CDK4/6 in #thymictumors @SukiPaddaMD thymoma versus thymic carcinoma diagnosis in autoimmune syndromes @gotoPER #ilc2021 with cochairs @HwakeleeMD @drgandara @DrRoyHerbstYale @CedarsSinai (@donnashort)
over 2 years ago
CDK4 (Cyclin-dependent kinase 4)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login